AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

Khan most recently served as executive vice president, head of commercial development at Complete HealthVizion ...

All attendees shared a vested interest in the rapidly evolving cancer treatment landscape. Nowhere was the vastness of that ...

Using the right language in disease awareness campaigns can help help save lives. Here we share top tips on how to use ...

The company formerly known as BeiGene announced that the Committee for Medicinal Products for Human Use (CHMP) has ...

The Considered has announced the appointment of Rob Fuller as its new chief strategy officer. Fuller brings over two decades ...

In Measure for Measure, Lucio points out the damage that doubts can do: ‘Our doubts are traitors, and make us lose the good ...

Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research ...

UCB has shared promising results from a late-stage study of fenfluramine in patients with an ultra-rare form of epilepsy. The ...

Crouch most recently served as therapeutic lead, oncology and specialty medicine for international developed markets at ...

With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...

Using technology to make your exhibitions stand out in 2025. In today’s fast-paced experience economy, pharma companies can ...